Sensible Medical Innovations Names Dr. Abraham Ludomirski CEO
Will further the implementation and commercialization of its ReDS™ technology – a cutting edge device for measuring and monitoring pulmonary congestion.
United States Abraham Avi Ludomirski Recro Pharma Maternal Fetal Medicine Division Aviv University Medical School University Of Pennsylvania
Source: einnews.com